Ocugen (OCGN) Interest Expenses (2014 - 2026)
Ocugen posted quarterly Interest Expenses of $1.3 million for Q1 2026, up 5.01% year-on-year from $1.3 million in Q1 2025, and down 0.9% on a QoQ basis from $1.3 million in Q4 2025.
Ocugen (OCGN) has 10 years of Interest Expenses data on file, last reported at $1.3 million in Q1 2026.
- For the quarter ending Q1 2026, Interest Expenses rose 5.01% year-over-year to $1.3 million; the trailing twelve-month figure through Mar 2026 stood at $4.0 million (up 110.17% YoY), and the FY2025 full-year result was $5.2 million, up 654.07% from the prior year.
- Interest Expenses for Q1 2026 stood at $1.3 million, down from $1.3 million in the prior quarter.
- Across five years, Interest Expenses topped out at $1.3 million in Q4 2025 and bottomed at $29000.0 in Q3 2024.
- The 3-year median for Interest Expenses is $1.3 million (2025), against an average of $975500.0.
- The widest annual swing landed in 2025, when Interest Expenses soared 4431.03%; it then increased 5.01% in 2026.
- A 3-year view of Interest Expenses shows it stood at $601000.0 in 2024, then soared by 121.63% to $1.3 million in 2025, then retreated by 0.9% to $1.3 million in 2026.
- The last three Interest Expenses figures came in at $1.3 million (Q1 2026), $1.3 million (Q4 2025), and $1.3 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int Expense (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - | 22,854.00 |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn | -5.50 Mn |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - | 61,000.00 |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn | - |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - | -332,000.00 |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn | 12.90 Mn |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn | 69.29 Mn |
| 10 | Ocugen | 452.01 Mn | 452.01 Mn | - | 1.32 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1.32 Mn |
| Mar 31, 2026 | 1.32 Mn |
| Dec 31, 2025 | 1.33 Mn |
| Dec 31, 2025 | 1.33 Mn |
| Sep 30, 2025 | 1.31 Mn |
| Sep 30, 2025 | 1.31 Mn |
| Mar 31, 2025 | 1.26 Mn |
| Mar 31, 2025 | 1.26 Mn |
| Dec 31, 2024 | 601,000.00 |
| Dec 31, 2024 | 601,000.00 |
| Sep 30, 2024 | 29,000.00 |
| Sep 30, 2024 | 29,000.00 |
| Dec 31, 2021 | 20,000.00 |
| Dec 31, 2021 | 20,000.00 |
| Sep 30, 2021 | 19,000.00 |
| Sep 30, 2021 | 19,000.00 |
| Jun 30, 2021 | 20,000.00 |
| Jun 30, 2021 | 20,000.00 |
| Mar 31, 2021 | 20,000.00 |
| Mar 31, 2021 | 20,000.00 |
| Dec 31, 2020 | 166,000.00 |
| Dec 31, 2020 | 166,000.00 |
| Sep 30, 2020 | 292,000.00 |
| Sep 30, 2020 | 292,000.00 |
| Jun 30, 2020 | 248,000.00 |
| Jun 30, 2020 | 248,000.00 |
| Mar 31, 2020 | 15,000.00 |
| Mar 31, 2020 | 15,000.00 |
| Dec 31, 2019 | 14,828.00 |
| Dec 31, 2019 | 14,828.00 |
| Sep 30, 2019 | 796,141.00 |
| Sep 30, 2019 | 796,141.00 |
| Jun 30, 2019 | 261,562.00 |
| Jun 30, 2019 | 261,562.00 |
| Mar 31, 2019 | 695,469.00 |
| Mar 31, 2019 | 695,469.00 |
| Dec 31, 2018 | 715,280.00 |
| Dec 31, 2018 | 715,280.00 |
| Sep 30, 2018 | 1.00 Mn |
| Sep 30, 2018 | 1.00 Mn |
| Dec 31, 2016 | 5,000.00 |
| Dec 31, 2016 | 5,000.00 |
| Sep 30, 2016 | 20,000.00 |
| Sep 30, 2016 | 20,000.00 |
| Jun 30, 2016 | 17,000.00 |
| Jun 30, 2016 | 17,000.00 |
| Mar 31, 2016 | 19,000.00 |
| Mar 31, 2016 | 19,000.00 |
| Dec 31, 2015 | 22,000.00 |
| Dec 31, 2015 | 22,000.00 |
| Sep 30, 2015 | 23,000.00 |
| Sep 30, 2015 | 23,000.00 |
| Jun 30, 2015 | 26,000.00 |
| Jun 30, 2015 | 26,000.00 |
| Mar 31, 2015 | 62,000.00 |
| Mar 31, 2015 | 62,000.00 |
| Dec 31, 2014 | 132,000.00 |
| Dec 31, 2014 | 132,000.00 |
| Sep 30, 2014 | 19,000.00 |
| Sep 30, 2014 | 19,000.00 |